Skip to main content
. 2023 Jun 27;64(7):2733–2745. doi: 10.1021/acs.jcim.3c00536

Figure 6.

Figure 6

Ligand interaction diagrams of inhibitors into the binding site of SARS-CoV-2 RNA-dependent-RNA-polymerase (RdRp). The inhibitors are (A) Remdesivir triphosphate (RTP), (B) Compound a2, and (C) Compound a1. The binding free energy (kcal/mol) for the protein-inhibitor complexes predicted by the MM/GBSA method.